Evidence of Inhaled Tobramycin in Non-Cystic Fibrosis Bronchiectasis
There is currently less experience with inhaled tobramycin in non-cystic fibrosis bronchiectasis than in cystic fibrosis (CF). Intravenous formulation and solution for inhalation (TSI) have been studied in non-CF bronchiectasis patients with chronic P. aeruginosa bronchial infection. An improvement...
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Bentham Open
2015
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397829/ |